CONCIERGE GLOBAL PARA LA SALUD
El Concierge LPG coordina todas tus necesidades médicas desde tu primera consulta y te aporta tranquilidad a lo largo del tratamiento.
Con sede en la prestigiosa calle Harley Street de Londres y una red que cubre Los Angeles, Hong Kong y Dubái, la clínica les ofrece un servicio de concierge de salud liderado por médicos a los particulares que tienen un elevado patrimonio neto y a las organizaciones corporativas.
Con sede en la prestigiosa calle Harley Street de Londres y una red que cubre Los Angeles, Hong Kong y Dubái, la clínica les ofrece un servicio de concierge de salud liderado por médicos a los particulares que tienen un elevado patrimonio neto y a las organizaciones corporativas.
UNA ATENCIÓN AFIANZADA
Si tú y tu familia pasan varios meses fuera del país por compromisos de negocios o tienen otra casa en el extranjero, The London General Practice puede apoyarlos conectándolos con los mejores doctores en las principales ciudades del mundo.
Con vínculos especialmente fuertes en los EE. UU. (por ej., en Nueva York, Boston, LA o Miami), Hong Kong y varias ciudades clave europeas; la clínica está ampliando su red a fin de abarcar otros territorios asiáticos y de Australasia.
Para saber más sobre este servicio o para agendar una cita con nuestros GP, llama al 0207 935 1000
VISITAS A DOMICILIO LAS 24 HORAS DEL DÍA, LLAMA AL +44 (0)207 935 1000.
Closed
Genetic Testing for Cancer
The panel determines whether you are at an increased risk to develop more than 57 inherited conditions, including:
- Breast cancer
- Colorectal (bowel) cancer
- Cutaneous melanoma
- Gastric cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Renal cell cancer
- Thyroid cancer
- Uterine cancer
- Additional hereditary cancer conditions
The full list of genes tested for and their related condition is below:
Gene(s) | Condition(s) | |
APC | Colorectal, endocrine, gastric, nervous system/brain, and pancreatic cancer, sarcoma | |
ATM | Breast, pancreatic, and prostate cancer | |
AXIN2 | Colorectal cancer | |
BAP1 | Renal/urinary tract cancer, melanoma | |
BARD1 | Breast cancer | |
BMPR1A | Colorectal, gastric, and pancreatic cancer | |
BRCA1 | Breast, gynaecologic, pancreatic, and prostate cancer | |
BRCA2 | Breast, gynaecologic, pancreatic, and prostate cancer, melanoma | |
BRIP1 | Breast and gynaecologic cancer | |
CDC73 | Endocrine and renal/urinary tract cancer | |
CDH1 | Breast, colorectal, and gastric cancer | |
CDK4 | Melanoma | |
CDKN2A | Nervous system/brain and pancreatic cancer, melanoma | |
CHEK2 | Breast, colorectal, endocrine, gynaecologic, and prostate cancer | |
DICER1 | Endocrine, gynaecologic, nervous system/brain, and renal/ urinary tract cancer, sarcoma | |
EPCAM | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
FH | Renal/urinary tract cancer, sarcoma | |
FLCN | Renal/urinary tract cancer | |
GREM1 | Colorectal cancer | |
HOXB13 | Prostate cancer | |
KIT | Gastric cancer, sarcoma | |
MAX | Endocrine cancer | |
MEN1 | Endocrine, nervous system/brain, and pancreatic cancer | |
MET | Renal/urinary tract cancer | |
MITF | Melanoma | |
MLH1 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
MSH2 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
MSH3 | Colorectal cancer, includes reporting of carrier status | |
MSH6 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
MUTYH | Colorectal cancer | |
NBN | Breast and prostate cancer | |
NF1 | Breast, endocrine, gastric, and nervous system/brain cancer | |
NF2 | Nervous system/brain cancer | |
NTHL1 | Colorectal cancer, includes reporting of carrier status | |
PALB2 | Breast and pancreatic cancer | |
PDGFRA | Gastric cancer, sarcoma | |
PMS2 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
POLD1 | Colorectal cancer | |
POLE | Colorectal cancer | |
PRKAR1A | Endocrine and nervous system/brain cancer, sarcoma | |
PTCH1 | Nervous system/brain and skin cancer, sarcoma | |
PTEN | Breast, colorectal, endocrine, gynaecologic, nervous system/brain and, renal/urinary tract cancer, melanoma | |
RAD51C | Breast and gynaecologic cancer | |
RAD51D | Breast and gynaecologic cancer | |
RB1 | Melanoma, retinoblastoma, sarcoma | |
RET | Endocrine cancer | |
SDHA | Endocrine and gastric cancer, sarcoma | |
SDHAF2 | Endocrine cancer | |
SDHB | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
SDHC | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
SDHD | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
SMAD4 | Colorectal, gastric, and pancreatic cancer | |
SMARCA4 | Gynaecologic cancer | |
SMARCB1 | Nervous system/brain and renal/urinary tract cancer | |
STK11 | Breast, colorectal, gastric, gynaecologic, and pancreatic cancer | |
TMEM127 | Endocrine cancer | |
TP53 | Breast, endocrine, gastrointestinal, genitourinary, gynaecologic, hematologic, nervous system/brain, and skin cancer, sarcoma | |
TSC1 | Nervous system/brain, pancreatic, and renal/urinary tract cancer | |
TSC2 | Nervous system/brain, pancreatic, and renal/urinary tract cancer | |
VHL | Endocrine, nervous system/brain, pancreatic, and renal/urinary tract cancer | |
WT1 | Renal/urinary tract cancer |
Cardiovascular Genetic Testing
The panel determines whether you are at an increased risk to develop more than 45 inherited conditions, including:
- Aortopathies
- Arrhythmias
- Cardiomyopathies
- Genetic forms of high blood pressure and
high cholesterol - Thrombophilia
- Additional hereditary cardiovascular conditions
The full list of genes tested for and their related condition is below:
Gene(s) | Condition(s) | |
ACTA2 | Aortopathy | |
ACTC1 | Cardiomyopathy, congenital heart disease | |
ACTN2 | Arrhythmia, cardiomyopathy | |
ACVRL1 | Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension | |
APOB | Familial hypercholesterolemia, familial hypobetalipoproteinemia | |
BAG3 | Cardiomyopathy, neuromuscular condition | |
BMPR2 | Pulmonary arterial hypertension | |
CACNA1C | Arrhythmia, cardiomyopathy, congenital heart disease | |
CACNB2 | Arrhythmia | |
CALM1 | Arrhythmia | |
CALM2 | Arrhythmia | |
CALM3 | Arrhythmia | |
CASQ2 | Arrhythmia, includes reporting of carrier status | |
CAV1 | Pulmonary arterial hypertension | |
CAV3 | Arrhythmia, cardiomyopathy, neuromuscular condition | |
COL3A1 | Aortopathy | |
CRYAB | Cardiomyopathy, neuromuscular condition | |
CSRP3 | Cardiomyopathy | |
DES | Arrhythmia, cardiomyopathy, neuromuscular condition | |
DMD | Cardiomyopathy, neuromuscular condition | |
DSC2 | Arrhythmia, cardiomyopathy | |
DSG2 | Arrhythmia, cardiomyopathy | |
DSP | Arrhythmia, cardiomyopathy | |
EMD | Arrhythmia, cardiomyopathy, neuromuscular condition | |
ENG | Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension | |
F2 | Hereditary thrombophilia | |
F5 | Hereditary thrombophilia | |
F9 | Hemophilia, hereditary thrombophilia | |
FBN1 | Aortopathy | |
FHL1 | Cardiomyopathy, neuromuscular condition | |
FLNC | Cardiomyopathy, neuromuscular condition | |
GDF2 | Hereditary hemorrhagic telangiectasia | |
GLA | Cardiomyopathy, lysosomal storage disease | |
GPD1L | Arrhythmia | |
HCN4 | Arrhythmia, cardiomyopathy | |
JUP | Arrhythmia, cardiomyopathy | |
KCNE1 | Arrhythmia | |
KCNE2 | Arrhythmia | |
KCNH2 | Arrhythmia | |
KCNJ2 | Arrhythmia | |
KCNQ1 | Arrhythmia | |
LAMP2 | Cardiomyopathy, glycogen storage disease | |
LDLR | Familial hypercholesterolemia | |
LDLRAP1 | Familial hypercholesterolemia, includes reporting of carrier status | |
LMNA | Arrhythmia, cardiomyopathy, neuromuscular condition | |
MYBPC3 | Cardiomyopathy | |
MYH11 | Aortopathy | |
MYH7 | Cardiomyopathy, neuromuscular condition | |
MYL2 | Cardiomyopathy | |
MYL3 | Cardiomyopathy | |
MYLK | Aortopathy | |
NKX2-5 | Arrhythmia, congenital heart disease | |
PCSK9 | Familial hypercholesterolemia | |
PKP2 | Arrhythmia, cardiomyopathy | |
PLN | Arrhythmia, cardiomyopathy | |
PRKAG2 | Arrhythmia, cardiomyopathy | |
PRKG1 | Aortopathy | |
PROC | Hereditary thrombophilia | |
PROS1 | Hereditary thrombophilia | |
RBM20 | Arrhythmia, cardiomyopathy | |
RYR2 | Arrhythmia, cardiomyopathy | |
SCN5A | Arrhythmia, cardiomyopathy | |
SERPINC1 | Hereditary thrombophilia | |
SGCD | Cardiomyopathy, neuromuscular condition | |
SMAD3 | Aortopathy | |
SMAD4 | Hereditary hemorrhagic telangiectasia | |
TCAP | Cardiomyopathy, neuromuscular condition | |
TGFB2 | Aortopathy | |
TGFB3 | Aortopathy, arrhythmia, cardiomyopathy | |
TGFBR1 | Aortopathy, multiple self-healing squamous epithelioma | |
TGFBR2 | Aortopathy | |
TMEM43 | Arrhythmia, cardiomyopathy | |
TNNC1 | Cardiomyopathy | |
TNNI3 | Arrhythmia, cardiomyopathy | |
TNNT2 | Arrhythmia, cardiomyopathy | |
TPM1 | Cardiomyopathy | |
VCL | Cardiomyopathy |
Combined Genetic Testing
When we test for cancer and cardiomyopathy combined we also screen for the following metabolic disorders:
Gene(s) | Condition(s) | |
ATP7B | Wilson disease, includes reporting of carrier status | |
CACNA1S | Hypokalemic periodic paralysis, malignant hyperthermia susceptibility | |
HAMP | Hereditary hemochromatosis, includes reporting of carrier status | |
HFE | Hereditary hemochromatosis, includes reporting of carrier status | |
HJV | Hereditary hemochromatosis, includes reporting of carrier status | |
OTC | Ornithine transcarbamylase deficiency | |
RYR1 | Malignant hyperthermia susceptibility, neuromuscular condition | |
SERPINA1 | Alpha-1 antitrypsin deficiency, includes reporting of carrier status | |
SLC40A1 | Hereditary hemochromatosis | |
TFR2 | Hereditary hemochromatosis, includes reporting of carrier status |